Forvis Mazars Wealth Advisors LLC Purchases 992 Shares of MetLife, Inc. $MET

Forvis Mazars Wealth Advisors LLC grew its stake in MetLife, Inc. (NYSE:METFree Report) by 4.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,455 shares of the financial services provider’s stock after buying an additional 992 shares during the quarter. Forvis Mazars Wealth Advisors LLC’s holdings in MetLife were worth $1,806,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Price T Rowe Associates Inc. MD increased its position in MetLife by 7.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider’s stock worth $2,126,734,000 after buying an additional 1,824,907 shares in the last quarter. Pzena Investment Management LLC increased its position in MetLife by 6.8% in the second quarter. Pzena Investment Management LLC now owns 9,144,635 shares of the financial services provider’s stock worth $735,412,000 after buying an additional 585,671 shares in the last quarter. Bank of New York Mellon Corp increased its position in MetLife by 0.4% in the first quarter. Bank of New York Mellon Corp now owns 8,862,835 shares of the financial services provider’s stock worth $711,597,000 after buying an additional 36,177 shares in the last quarter. Ameriprise Financial Inc. increased its position in MetLife by 3.6% in the first quarter. Ameriprise Financial Inc. now owns 7,406,512 shares of the financial services provider’s stock worth $594,410,000 after buying an additional 259,993 shares in the last quarter. Finally, Northern Trust Corp increased its position in MetLife by 0.8% in the first quarter. Northern Trust Corp now owns 7,109,423 shares of the financial services provider’s stock worth $570,816,000 after buying an additional 57,221 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the company. Wolfe Research upgraded MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Weiss Ratings reissued a “buy (b)” rating on shares of MetLife in a research note on Wednesday, October 8th. Jefferies Financial Group lifted their target price on MetLife from $100.00 to $103.00 and gave the company a “buy” rating in a research note on Monday, August 11th. Barclays lifted their target price on MetLife from $93.00 to $98.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company lifted their target price on MetLife from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and an average target price of $95.18.

Check Out Our Latest Stock Report on MetLife

MetLife Stock Performance

NYSE MET opened at $78.55 on Monday. The stock has a market capitalization of $52.24 billion, a PE ratio of 13.31, a P/E/G ratio of 0.71 and a beta of 0.86. The business has a 50 day simple moving average of $80.20 and a two-hundred day simple moving average of $78.10. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing the consensus estimate of $2.32 by ($0.30). The firm had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.28 EPS. On average, research analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th will be issued a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a yield of 2.9%. The ex-dividend date is Tuesday, November 4th. MetLife’s dividend payout ratio (DPR) is currently 38.47%.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.